ArticleVirus research2026

Optimization of lipid nanoparticles loaded with ribonucleoprotein-oligonucleotide complexes for in vivo delivery of a CRISPR/Cas9 system targeting hepatitis B virus.

Rupaly Akhter et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.